Envestnet Asset Management
FLGT icon

Envestnet Asset Management’s Fulgent Genetics FLGT Stock Holding History

Envestnet Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,428
Closed -$261K – 4874
2026
Q1 		$261K Buy
+16,428
New +$357K ﹤0.01% 4358
2021
Q2 		– Sell
-2,348
Closed -$227K – 3653
2021
Q1 		$227K Buy
+2,348
New +$242K ﹤0.01% 3281

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Envestnet Asset Management's FLGT Position: Q2 2026 in Review

Envestnet Asset Management sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 16,428 shares — an estimated $261K sold.

Envestnet Asset Management first reported a position in FLGT in Q1 2021 and held it in 2 quarters. The position peaked at $261K in Q1 2026. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Envestnet Asset Management reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 16,428 Fulgent Genetics shares in Q2 2026, an estimated $261K.
  • Envestnet Asset Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 2 quarters.
  • Envestnet Asset Management's Fulgent Genetics position peaked at $261K in Q1 2026.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.